Contract awardedCell analysis and life-science research instruments

Bioreactor for NHS Blood and Transplant comes from BioLogic Technologies

NHS Blood and Transplant bought a parallel small-scale bioreactor system from BioLogic Technologies Limited, with maintenance and consumables included.

The system is for the Clinical Biotechnology Centre (CBC), which manufactures viral vector products for cell and gene therapies. The CBC expects to take on multiple viral vector projects each year as part of a Medical Research Council funded gene therapy network. Each project goes through process development at small scale first, to pin down its critical process parameters and lower the risk of a failed batch in GMP manufacturing.

The open tender drew one bid, with price counting for 70% of the score, quality 20% and social value 10%. BioLogic won in December 2025 at £811,075, against an estimate of £680,000. The five-year contract runs to January 2031 and could be extended to ten years.

Alert me to similar tenders

Contract ends January 2031

What
Cell analysis and life-science research instruments
Value
£811,075
How it was bought
Open
1 bid
Dates and next
Jan 2026 to Jan 2031
Option to Jan 2036

How it was bought

4 official notices
  1. 7 Nov 2025Tender noticeAtamis
  2. 12 Dec 2025Bids closed1 bid
  3. 19 Dec 2025Award noticeFind a Tender
  4. 19 Dec 2025Award noticeFind a Tender
  5. 15 Jan 2026Award noticeFind a Tender
  6. 19 Jan 2026Contract starts
  7. 18 Jan 2031Contract endsUp to Jan 2036 with extension

NHS Blood and Transplant has bought this 8 times since 2021

Last bought
Sep 2026
Typical length
4 years
Typical value
£595,650
Suppliers used
5
AwardedContractWon byValue
Sep 2026Locked2 yearsLocked£291,955
Jan 2026This purchase5 yearsBioLogic Technologies Limited£811,075
Dec 2025Locked4 yearsLocked£434,726
Apr 2025Locked4 yearsLocked£5.2m
Mar 2024Locked11 monthsLocked£900,000

and 3 more

Suppliers NHS Blood and Transplant has used

SupplierContractsValue
Locked2£6.1m
Locked2£789,445
BioLogic Technologies Limited Won this one1£811,075
Locked1£434,726
Locked1£291,955
See the contracts and who won them

Figures to 21 November 2026

How it compares

With every cell analysis and life-science research instruments award since 2021

Half of awards fall between £58,000 and £260,854Median £115,000

Awards
435
Firms that won them
164
Median award
£115,000
of 413 with a value
This award
Bigger than 94%
of them
Typical length
1 year
In South West
37 awards

BioLogic Technologies Limited ranks 69th of 164 firms for cell analysis and life-science research instruments awards since 2021.

RankFirmAwardsValue
1Locked18£4.4m
2Locked15£8.3m
2Locked15£2.52m
4Locked13£4.8m
5Locked12£2.6m
6Locked11£3.43m
69BioLogic Technologies Limited Won this one1£811,075
See who wins this work

Cell analysis and life-science research instruments at other buyers

NHS Blood and Transplant has awarded 505 contracts since 2021.

See NHS Blood and Transplant's page
  • BioLogic Technologies Limited has won 2 public contracts since 2021.